Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort vs Pulmicort in asthmatic children (SAPLING)
NCT00646529Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2002
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Jul 2002; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00646529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646529.